| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 95165 |
Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials |
5,385 |
2,181 |
$1.22M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,588 |
12,224 |
$778K |
| 95004 |
Percutaneous tests with allergenic extracts, immediate type reaction |
3,369 |
3,086 |
$770K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,251 |
8,146 |
$739K |
| 31231 |
|
4,087 |
3,431 |
$536K |
| 31237 |
|
1,217 |
894 |
$449K |
| 86003 |
|
1,499 |
1,365 |
$447K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
5,863 |
4,983 |
$435K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,174 |
2,861 |
$388K |
| 95117 |
|
32,495 |
14,810 |
$345K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
947 |
765 |
$122K |
| 31295 |
|
133 |
75 |
$115K |
| 30140 |
|
552 |
349 |
$112K |
| 95800 |
|
123 |
112 |
$95K |
| 70486 |
|
855 |
711 |
$91K |
| 95115 |
|
8,453 |
3,901 |
$78K |
| 30117 |
|
279 |
122 |
$76K |
| 31575 |
|
417 |
337 |
$33K |
| 30469 |
|
17 |
15 |
$23K |
| 92567 |
|
1,559 |
1,319 |
$20K |
| 69210 |
|
609 |
470 |
$17K |
| 82785 |
|
832 |
777 |
$16K |
| 96401 |
|
320 |
209 |
$16K |
| 31255 |
|
63 |
44 |
$15K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
405 |
341 |
$13K |
| 61782 |
|
110 |
83 |
$12K |
| 92552 |
|
544 |
502 |
$12K |
| 92557 |
|
297 |
267 |
$12K |
| 31525 |
|
44 |
39 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
682 |
561 |
$9K |
| 92511 |
|
54 |
52 |
$8K |
| J2357 |
Injection, omalizumab, 5 mg |
94 |
72 |
$7K |
| 92556 |
|
208 |
199 |
$5K |
| 90674 |
|
207 |
171 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
140 |
126 |
$4K |
| 99215 |
Prolong outpt/office vis |
28 |
26 |
$4K |
| 92555 |
|
169 |
154 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
132 |
124 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
994 |
590 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
155 |
98 |
$2K |
| 92550 |
|
102 |
76 |
$2K |
| 70220 |
|
37 |
30 |
$956.83 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
41 |
41 |
$843.28 |
| 30801 |
|
17 |
15 |
$832.93 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
757 |
557 |
$382.94 |
| 92587 |
|
14 |
12 |
$355.92 |
| 99051 |
|
28 |
25 |
$347.28 |
| 36415 |
Collection of venous blood by venipuncture |
56 |
56 |
$253.91 |